| Norman Marcus, MD | |
|
30 E 40th St, Ste 1100, New York, NY 10016-1201 | |
| (212) 532-7999 | |
| (212) 532-5957 |
| Full Name | Norman Marcus |
|---|---|
| Gender | Male |
| Speciality | Pain Medicine - Pain Medicine |
| Location | 30 E 40th St, New York, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679597744 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 102747 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Norman Marcus, MD 30 E 40th St, Ste 1100, New York, NY 10016-1201 Ph: (212) 532-7999 | Norman Marcus, MD 30 E 40th St, Ste 1100, New York, NY 10016-1201 Ph: (212) 532-7999 |
News Archive
Yesterday, Illinois became the 40th state where legislators have introduced, or will introduce, legislation modeled after the American Legislative Exchange Council's (ALEC) Freedom of Choice in Health Care Act. Illinois House Bill 6842 prohibits a requirement to purchase health insurance and would provide the state with protection in a constitutional challenge of the federal health reform bill.
A new study, presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons, identifies predictors of complications and mortality following a hip fracture, including dialysis, cardiac disease, diabetes, and a longer time before surgery - the only modifiable risk factor when patients are hospitalized.
According to the American Cancer Society, breast cancer is the most common cancer among American women, except for skin cancers, and about one in eight women in the United States will develop invasive breast cancer during their lifetime. The National Institutes of Health recently awarded a $1.08 million grant to The University of Texas at San Antonio to combine computational modeling with biological information to advance our understanding of what may cause breast cells to become cancerous.
Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for its lead product, TissuGlu Surgical Adhesive in the United States.
› Verified 1 days ago
Nilufer Guleyupoglu, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 369 Lexington Ave, Suite 800, New York, NY 10017 Phone: 347-252-6732 | |
Semih Gungor, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 535 E 70th St, Hss Dept. Of Anesthesiology, New York, NY 10021 Phone: 212-774-2176 Fax: 212-517-4881 | |
Dr. Mitchell Chandler, D.O. Pain Medicine Medicare: Medicare Enrolled Practice Location: 245 W 74th St Apt 1f, New York, NY 10023 Phone: 212-423-6262 | |
Dr. Suzanne Gutierrez Teissonniere, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1275 York Ave, New York, NY 10065 Phone: 646-888-1900 | |
Suelane Sousa Do Ouro, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W 57th St, Suite 608, New York, NY 10019 Phone: 212-581-4488 Fax: 212-581-4141 | |
Dr. Yasha Magyar, D.O. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 369 Lexington Ave, 18b, New York, NY 10017 Phone: 646-467-2737 Fax: 888-277-9455 | |
Michael Schechter, DO Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2398 Broadway, New York, NY 10024 Phone: 212-721-2111 Fax: 212-510-8134 |